Escalofríos

5-HTP is the immediate precursor to serotonin (5-HT), a neurotransmitter important for hippocampal memory consolidation and synaptic plasticity. While 5-HTP is primarily studied for mood disorders, serotonin's role in memory—particularly in modulating glutamate-dependent long-term potentiation—is well-documented. Limited direct clinical evidence exists for 5-HTP specifically on memory endpoints versus its broader neurochemical role.

Multiple RCTs and meta-analyses indicate Acetyl-L-Carnitine (ALCAR) may slow cognitive decline and improve memory in mild cognitive impairment and early Alzheimer's disease. A 28-week double-blind RCT in vascular cognitive impairment found 1,500 mg/day significantly improved Montreal Cognitive Assessment scores. A meta-analysis of double-blind RCTs concluded ALCAR shows benefit in MCI and mild Alzheimer's disease, though effect sizes are modest. Doses studied range from 1,500–4,000 mg/day.

Tyrosine supplementation has been shown in controlled trials to preserve working memory specifically under conditions of acute physical stress such as cold exposure and sleep deprivation. The effect appears context-dependent: benefits are seen when catecholamines are depleted by stressors, not under normal resting conditions. NALT acts as a prodrug that must be converted to L-tyrosine to exert these effects.

ALA supports memory function through neuroprotective mechanisms, including reduction of neuroinflammation, inhibition of amyloid-beta toxicity, and promotion of synaptic plasticity. Animal models show robust memory-protective effects; human RCT evidence is emerging and preliminary.

ALA has been investigated in Alzheimer's disease and age-related cognitive decline due to its antioxidant and anti-neuroinflammatory properties. Clinical RCTs in AD patients have shown variable results, with some pilot studies reporting improved MMSE scores in diabetic AD patients. Overall clinical evidence in non-demented older adults is limited and mixed, with one open-label pilot (n=15, 600 mg/day, 12 weeks) finding no significant effect on cognition or mood.

Algal oil DHA has been directly tested for memory improvement in clinical trials. The landmark MIDAS trial (n=485, 900 mg algal DHA/day, 24 weeks) found significantly fewer paired associative learning errors versus placebo in healthy older adults with mild memory complaints. A meta-analysis confirmed that DHA+EPA doses above 580 mg/day improve episodic memory in adults with mild memory complaints.

Clinical and animal study evidence supports almond consumption improving specific memory domains. A 6-month human RCT found significant improvements in visual memory and spatial working memory at 3 oz/day. Preclinical studies in rats demonstrate anti-amnesic effects via antioxidant mechanisms and preservation of brain acetylcholine levels.

A 2023 study in the Journal of Agricultural and Food Chemistry found that 4-week AGIQ treatment in mice significantly improved learning and memory function, linked to Akkermansia enrichment in the gut, increased serum and hippocampal taurine, and upregulation of hippocampal antioxidant defense enzymes. Evidence is preclinical only.

Animal studies and a neuroprotective review demonstrate that A. galanga constituents (galangin, ACA) inhibit acetylcholinesterase and protect against cognitive decline. Human RCTs of the standardised extract show improvements in accuracy and cognitive performance metrics relevant to memory function.

DHA is the dominant structural omega-3 fatty acid in brain neurons, with the highest concentration in the hippocampus, a region critical for memory formation. Randomized controlled trials have shown DHA supplementation improves memory and reaction time in healthy young adults. Observational studies associate higher omega-3 intake with lower beta-amyloid levels, a marker of Alzheimer's risk.

Multiple preclinical studies show that anemarrhena constituents — particularly timosaponin AIII, timosaponin B-II, and sarsasapogenin — improve learning and memory in rodent models of dementia, scopolamine-induced amnesia, and vascular dementia. Mechanisms include AChE inhibition and increased hippocampal acetylcholine.

Apple juice and apple polyphenols have been studied for neuroprotective and memory-supporting effects. Human studies and epidemiological data suggest apple consumption may support cognitive performance, with mechanistic evidence from quercetin's neuroprotective and anti-neuroinflammatory properties.

Multiple human RCTs have demonstrated that Aronia melanocarpa extract supplementation improves cognitive performance, including psychomotor speed, attention, and reaction time, along with increases in serum BDNF. Animal studies show attenuation of memory impairment via AChE inhibition and increased hippocampal BDNF and p-CREB expression.

Ashwagandha (Withania somnifera) is a revered Ayurvedic adaptogen used for millennia for memory, cognition, and mental vitality. A 2021 double-blind RCT (n=130 stressed adults, 300 mg/day, 90 days) found significantly improved recall memory and reduced error rates on CANTAB neuropsychological testing versus placebo. A 2024 RCT found 225 mg/day improved memory, attention, and executive function in healthy young adults.

Human RCTs report modest but significant improvements in memory and cognitive performance in middle-aged and older adults at 6–12 mg/day for 8–12 weeks. A Japanese RCT found improvements in memory test scores in healthy volunteers with age-related mild forgetfulness. Benefits are attributed to astaxanthin crossing the blood-brain barrier and reducing neuronal oxidative stress.

Preclinical studies from South Korea and transgenic mouse models document that Aster tataricus extract (ATE) improves memory dysfunction, modulates hippocampal cholinergic activity, prevents amyloid-β aggregation, and reduces neuronal apoptosis. This evidence base is limited to animal and cell studies with no human trials.

Bacopa monnieri (Brahmi) has long been used in Ayurvedic medicine for memory and learning. A systematic review of 6 RCTs found Bacopa improved memory free recall across 9 of 17 tests. A 12-week double-blind RCT in adults ≥65 years (n=54, 300 mg/day) showed enhanced delayed word recall versus placebo. Active constituents bacosides A and B are thought to facilitate nerve impulse transmission.

Bacopin is a standardized extract of Bacopa monnieri, the same Ayurvedic herb studied extensively for memory and cognition. The active bacosides in Bacopin are the same compounds shown in RCTs to improve memory free recall and verbal learning. Its evidence base is shared with Bacopa monnieri standardized extracts used in clinical trials.

Bacosides are the principal active saponins isolated from Bacopa monnieri responsible for its memory-enhancing effects. Preclinical studies demonstrate bacosides facilitate nerve impulse transmission and reverse chemically induced amnesia. Clinical RCTs using standardized Bacopa extracts (calibrated to bacoside content) show improved memory free recall and verbal learning.

Icariin attenuates memory and learning deficits in multiple rodent models of Alzheimer's disease and cognitive impairment, reducing amyloid-beta deposition, tau phosphorylation, and synaptic damage. The mechanism involves BDNF/TrkB/Akt pathway upregulation, improved brain insulin signaling, and anti-neuroinflammatory effects. All evidence is currently preclinical; human cognitive trials have not been conducted.

A 2015 placebo-controlled trial (n=40) showed that 300 mg holy basil leaf extract improved reaction times and short-term memory over 30 days. A 2012 RCT (n=158) found 300 mg/day improved working memory and attention over 6 weeks. Preclinical data indicates basil polyphenols stimulate BDNF and NGF pathways relevant to memory consolidation.

Beetroot nitrate has been shown to increase cerebral blood flow, particularly to the prefrontal cortex, with some RCTs demonstrating improvements in cognitive performance under fatigue. However, the overall evidence is mixed and inconsistent, particularly for global cognition and long-term memory.

A phase IIa RCT in 70 amyloid-positive participants with mild cognitive impairment or mild Alzheimer's disease found that 12 months of benfotiamine resulted in 43% lower ADAS-Cog score increase (less cognitive decline, p=0.125) and 77% lower worsening on the CDR scale (p=0.034). An earlier open-label study of 5 patients showed an average 3.2-point MMSE improvement over 18 months.

An RCT in 60 healthy older adults found B. longum BB68S (5×10¹⁰ CFU/day, 8 weeks) significantly improved immediate memory, delayed memory, attention, and visuospatial function as measured by the RBANS neuropsychological battery. Preclinical data in Alzheimer's disease mouse models also show B. longum BORI reduced amyloid pathology and improved memory.

Bilobalide is a sesquiterpene trilactone comprising approximately 2.6–3.2% of standardized Ginkgo biloba extract, contributing to its neuroprotective properties. It modulates GABA-A receptors, protects against ischemia-induced neuronal damage, and contributes to the cognitive effects observed in EGb 761 clinical trials. Evidence is derived from the context of the full standardized extract studies.

Platycladus orientalis seed extract has been shown in 5xFAD transgenic mice (an Alzheimer's model) to reduce amyloid-beta plaque deposition and promote memory abilities. Earlier studies also demonstrated amelioration of amygdala-lesion-induced memory deficits in mice. These findings provide preclinical support for TCM's traditional claim that biota seed 'benefits intelligence.'

Two placebo-controlled clinical trials demonstrated that N. sativa seed (500 mg twice daily for 9 weeks in elderly men; 500 mg once daily for 4 weeks in adolescents) significantly improved memory, cognition, and attention. Mechanistic evidence includes acetylcholinesterase inhibition and antioxidant protection of hippocampal neurons.

Piperine demonstrated cognitive-enhancing effects in streptozotocin-induced rat models of Alzheimer's-type dementia and scopolamine-induced cognitive deficit. It protects hippocampal neurons, inhibits neuroinflammation, and crosses the blood-brain barrier. Human evidence is currently absent; all meaningful evidence is preclinical.

Caffeine and L-theanine in black tea improve aspects of memory performance including delayed word recognition reaction time and working memory in clinical trials. Evidence is acute and largely from supplementation studies with isolated compounds rather than brewed black tea specifically.

Blackberry anthocyanins are part of the berry polyphenol class consistently associated with improved cognitive performance, particularly memory, in aging animal models and human observational studies. Cell studies confirm blackberry polyphenols protect neuronal cells from oxidative injury relevant to memory-associated brain regions.

A. scholaris bark extract showed nootropic (memory-enhancing) activity in rodent cognitive models. In passive avoidance and elevated plus maze tests, pretreatment with methanolic bark extract (100–500 mg/kg) augmented acquisition and retention of learned tasks compared with piracetam as a positive control.

Multiple RCTs show blueberry supplementation improves delayed memory and paired associate learning in older adults and those with mild cognitive impairment. A 2019 systematic review of 11 clinical studies confirmed cognitive benefits, particularly for delayed memory and executive function.

The same USDA dietary manipulation studies (Penland, 1994) found that low boron significantly impaired encoding, short-term memory (all three studies), and long-term memory (one study) in older adults versus adequate intake. EEG data corroborated poorer neural processing during the low-boron condition.

Human RCTs show Boswellia-containing formulas improve memory and cognitive function. A double-blind RCT in 70 older adults found a B. serrata/Melissa officinalis combination improved memory after one month. A separate placebo-controlled trial in TBI patients (n=80) demonstrated significant improvement in RAVLT, DSST, and TMT-B scores with a boswellic acid formula.

Bovine liver provides choline, B12, folate, and niacin — nutrients with documented roles in memory and cognitive function. Choline is required for acetylcholine synthesis. B12 and folate deficiencies cause cognitive impairment and memory loss. An RCT in Egyptian children found liver meatball consumption improved cognitive predictors including memory-related outcomes.

Cistanche tubulosa glycosides (Orobanchaceae/broomrape family) have been investigated clinically for Alzheimer's disease. An open-label uncontrolled study in 18 AD patients found cognitive scores were largely stabilized over 48 weeks with Memoregain® (cistanche glycoside capsules), though changes were statistically insignificant. Preclinical data shows neuroprotective and memory-enhancing properties of phenylpropanoid glycosides.

Butyrate improves memory in preclinical models via HDAC inhibition, which increases BDNF expression and histone acetylation in the hippocampus. Animal models show rescue of spatial, contextual, and fear memory. Human evidence remains indirect via HDAC inhibitor clinical trials.

C. crista seed kernel extracts have demonstrated nootropic (memory-enhancing) activity in scopolamine-induced amnesia models in mice, outperforming comparison with the standard drug piracetam. Additionally, leaf aqueous extract showed anti-amyloidogenic properties relevant to Alzheimer's disease.

Caffeine acutely enhances aspects of memory performance—particularly working memory and attention-dependent memory tasks—via adenosine receptor blockade and downstream dopaminergic enhancement. The large UK Biobank study found better prospective and paired-associate memory in recent caffeine users. Effects are dose-dependent and context-dependent, with chronic high-dose use potentially impairing hippocampal working memory.

DHA, the primary omega-3 in calamari oil, is the most abundant fatty acid in the brain and plays a structural role in neuronal membranes critical for memory consolidation. Multiple RCTs and a systematic review of 11 RCTs found DHA supplementation supported memory and hippocampal volume preservation, particularly in early-stage cognitive decline.

MCT oil formulas rich in caprylic acid have shown improvements in working memory and episodic memory in small human trials, most notably in older adults and those with mild cognitive impairment. The mechanism involves ketone-based alternative cerebral fueling. Effects appear strongest when baseline memory is already declining.

Green tea catechins have demonstrated effects on memory and cognitive function in animal models and human RCTs. A Japanese RCT found daily consumption of 336.4 mg decaffeinated green tea catechins improved cognitive function and working memory in adults aged 50–69 with mild cognitive decline.

Cauliflower is a significant dietary source of choline, which is essential for acetylcholine neurotransmitter synthesis and phosphatidylcholine membrane integrity—both critical for memory and cognitive function. Insufficient choline is associated with increased risk of age-related cognitive decline.

Nobiletin and tangeretin from Chen Pi demonstrate memory-improving effects in multiple animal models of cognitive impairment including Alzheimer's disease models. Nobiletin reduces soluble Aβ levels, reverses memory impairment, and reduces hippocampal oxidative stress. Evidence is currently preclinical.

Two RCTs show improvements in memory and cognitive performance in older adults consuming Montmorency tart cherry juice over 12 weeks. Proposed mechanisms include polyphenol-mediated reduction in blood pressure and oxidative stress, improving cerebral blood flow. Evidence is promising but based on small studies requiring replication.

Tanshinone IIA, a key compound in Danshen, has demonstrated neuroprotective and memory-preserving effects in multiple preclinical models including Alzheimer's disease and sleep deprivation-induced cognitive impairment. It promotes Aβ clearance, reduces neuroinflammation, and supports cholinergic function. Danshen was also traditionally used for insomnia and mental agitation, and is now under investigation for AD.

Chokeberry anthocyanins have demonstrated neuroprotective and memory-improving effects in animal models of cognitive impairment, including Aβ-induced memory damage and scopolamine-induced impairment. A human RCT in middle-aged individuals specifically assessed cognitive performance as an outcome. Clinical human evidence remains limited.

Choline is an essential nutrient serving as a precursor to acetylcholine—the primary neurotransmitter for memory and learning—and to phosphatidylcholine for neuronal membrane integrity. Deficiency impairs memory; supplementation via cholinergic forms (including citicoline, alpha-GPC) is documented to improve memory and cognitive function in RCTs. A 2023 comprehensive review confirmed choline compounds are effective strategies for boosting memory.

Chrysin protects against age- and oxidative-stress-induced memory deficits in rodent models by preserving hippocampal neurogenesis, reducing neuronal apoptosis, and restoring BDNF. It also protects against cognitive impairment in models of cerebral ischemia and clonazepam-induced cognitive deficit. Evidence is entirely preclinical.

A 2023 systematic review of 40 studies found that cinnamon and its bioactive compounds significantly improve cognitive function including memory and learning, primarily from in vivo animal data plus two clinical studies. Proposed mechanisms include inhibition of amyloid-beta oligomerization, reduction of tau aggregation, and improvement of brain insulin signaling.

Citicoline (CDP-choline) is among the most evidence-supported ingredients for memory and cognitive function. It is a precursor to both acetylcholine and phosphatidylcholine in the brain, supports membrane integrity, and improves working memory. Multiple RCTs and reviews document improvements in memory, particularly in adults with age-related cognitive decline, at doses of 250–1,000 mg/day.

Clinical RCTs show cocoa flavanols improve memory and cognitive processing speed, particularly in older adults. The CoCoA RCT (N=90 elderly) found significant dose-dependent improvements in Trail Making Test scores. Acute doses improve cerebral oxygenation and working memory in young adults.

Small clinical trials and systematic reviews show coconut/MCT oil reliably elevates plasma ketones, which can serve as an alternative brain fuel when glucose metabolism is impaired. Domain-specific memory improvements have been reported in mild cognitive impairment patients in some but not all trials. Evidence quality remains low.

MCTs from coconut oil raise ketone body levels, providing an alternative glucose-independent fuel for the brain, with demonstrated improvements in memory recall in individuals with mild cognitive impairment in human studies. A 2004 study in 20 subjects with Alzheimer's/MCI found significant memory improvement 90 minutes after MCT consumption vs. placebo. A 2024 meta-analysis concluded coconut oil improved cognitive scores in AD patients (p<0.05).

DHA is essential for hippocampal neuronal membrane function, synaptic plasticity, and memory consolidation. Supplementation studies show modest memory benefits, particularly in early-stage cognitive decline. Evidence in established dementia is less consistent.

Multiple RCTs with whole coffee cherry extract demonstrate measurable effects on working memory. A 2024 Nutrients RCT found CCE produced an 18.9% improvement in correct working memory responses versus 3.0% in placebo. A Robinson et al. (2019/2020) RCT in older adults with mild cognitive decline showed positive trends in memory testing over 28 days. BDNF elevation by coffee fruit extract may underpin long-term memory-supportive effects.

A systematic review and meta-analysis of RCTs found creatine supplementation significantly improved memory performance in healthy individuals, with the largest effects in older adults and under conditions of metabolic stress such as sleep deprivation. Short-term memory and intelligence/reasoning show the most consistent benefit across trials.

Multiple RCTs and a 2024 meta-analysis demonstrate that creatine monohydrate supplementation improves memory function in adults, with moderate-certainty evidence in this specific domain. Benefits are observed in both younger adults and older adults, and are particularly associated with states of low dietary creatine (e.g., vegetarians) or cognitive stress.

Curcumin, the principal polyphenol of turmeric (Curcuma longa), has extensive preclinical evidence for neuroprotection and anti-amyloid activity. A 2018 UCLA double-blind RCT (n=40, age 51–84, 90 mg twice daily, 18 months) found curcumin significantly improved memory scores by 28% and attention versus placebo, with reduced amyloid and tau on PET imaging.

High-dose alpha-tocopherol (2,000 IU/day) has shown moderate-quality evidence of slowing functional decline in mild-to-moderate Alzheimer's disease in the TEAM-AD RCT, though it does not improve cognitive function in MCI or prevent progression from MCI to dementia, per Cochrane review.

D-Asp acts as an endogenous NMDA receptor agonist in the brain, and elevated D-Asp levels are associated with enhanced hippocampal long-term potentiation (LTP) and improved spatial memory in animal models. A mouse study in Scientific Reports found that chronic D-Asp consumption selectively promoted intermediate-term spatial memory and upregulated hippocampal NMDA receptor subunits. Evidence is preclinical; human clinical trials on memory are absent.

Daidzin demonstrates dose-dependent memory-enhancing effects in animal models, with in silico data suggesting strong binding to acetylcholinesterase and dopamine receptors. Effects are proposed to occur via dopaminergic and cholinergic pathways. No human trials have been published.

DHA is the predominant omega-3 fatty acid in brain gray matter and is essential for neuronal membrane fluidity, synaptic function, and neuroprotection. Multiple RCTs show DHA supplementation can improve memory outcomes, particularly in older adults with age-related cognitive decline or low DHA status. Expert reviews identify omega-3 DHA as having among the strongest randomized evidence for memory support.

DHEA and DHEAS circulating levels decline markedly with aging and have been implicated in age-associated cognitive decline and memory loss. A double-blind study found 150 mg DHEA for 7 days improved episodic memory in healthy young men. However, a Cochrane review of five trials found no beneficial effect of DHEA supplementation on cognitive outcomes in healthy adults over 50.

DMAE pyroglutamate (1,500 mg/day) reversed scopolamine-induced short-term memory impairment in a clinical study of 24 healthy men, with supporting preclinical evidence of increased cortical acetylcholine and improved spatial memory in rats. Centrophenoxine (which delivers DMAE) has shown memory benefits in small older-adult trials. However, a large RCT of 242 patients with mild cognitive impairment taking DMAE for 24 weeks found no significant improvement in memory versus placebo. Overall human evidence is mixed and methodologically limited.

DHA is an integral component of neural membrane phospholipids and is positively associated with memory performance in observational and clinical data. A meta-analysis of RCTs found that DHA/EPA supplementation (>1 g/day) significantly improved episodic memory in adults with memory complaints. Results are most consistent in adults with existing memory deficits rather than in cognitively intact individuals.

Cuscuta chinensis and C. campestris extracts have been shown in animal studies to significantly improve scopolamine-induced memory deficits, performing well across multiple behavioral memory tests including the Morris water maze, passive avoidance test, and elevated plus-maze. Neural stem cell proliferation and antioxidant/anti-inflammatory mechanisms in brain tissue are proposed as underlying mechanisms.

Cornus officinalis and its active iridoid glycosides (morroniside, loganin, cornuside, cornel iridoid glycoside) have been studied in multiple animal models for memory protection, including Alzheimer's disease and aging models. Mechanisms include tau phosphorylation suppression, amyloid-β reduction, and synaptic protection.

DPA supplementation in aged rats produced neuro-restorative effects in the hippocampus, attenuating microglial activation and oxidative stress and improving spatial learning and long-term potentiation. These preclinical findings suggest DPA may protect memory-related neural circuits from age-related decline. Human-specific memory trials isolating DPA have not yet been conducted.

EGCG is the predominant polyphenol catechin in green tea with documented neuroprotective and pro-cognitive effects. It reduces amyloid-β aggregation, inhibits acetylcholinesterase mildly, and supports hippocampal neurogenesis. Epidemiological studies link regular green tea consumption to reduced cognitive decline. Human trial evidence for EGCG specifically on memory is emerging but limited compared to the broader green tea literature.

Choline in egg yolk is a precursor to acetylcholine, a neurotransmitter essential for memory formation. A randomized double-blind placebo-controlled trial in middle-aged and older Japanese adults found 300 mg/day egg yolk choline improved verbal memory scores over 12 weeks, and Finnish cohort data link higher egg intake to better cognitive function.

Higher serum EPA concentrations are positively associated with cognitive performance including memory in observational studies. A prospective study in coronary artery disease patients found EPA independently predicted MMSE scores. EPA may support memory indirectly through neuroinflammation reduction and cerebrovascular protection.

Multiple preclinical studies and at least one placebo-controlled human trial support eleuthero's memory-enhancing effects. Eleutheroside B and E improve memory in aged rats, and ciwujianosides from the leaf extract cross the blood-brain barrier and enhance memory in mice. A 2020 RCT in healthy humans showed cognitive/memory enhancement.

Observational studies demonstrate associations between higher circulating EPA/DHA levels and reduced risk of cognitive decline and dementia. Clinical trials of EPA on memory outcomes have produced mixed results, partly due to heterogeneous dosing and populations. Higher EPA blood levels appear protective against dementia progression in epidemiological evidence.

Eucommia extract inhibits AChE (supporting cholinergic neurotransmission relevant to memory), reduces Aβ deposition, and is investigated in Alzheimer's models. Active components including aucubin and geniposide have documented neuroprotective and anti-Alzheimer's activity in preclinical studies. No human memory trials exist.

A rat study (PMC3271546) showed that F. asafoetida gum extract produced dose-dependent improvement in memory on elevated plus-maze and passive avoidance models, alongside dose-dependent inhibition of brain cholinesterase. A 2024 human RCT also found secondary improvements in cognitive attention with asafoetida supplementation.

Fisetin promotes ERK-dependent LTP and memory consolidation in hippocampal circuits in multiple rodent models, including transgenic Alzheimer's and rapidly aging mice. It is among the most studied flavonoids for memory-related neuroprotection, though all evidence remains preclinical.

DHA is a critical structural component of neuronal membranes and synapses, supporting the mechanistic rationale for fish oil's role in memory. Clinical trial evidence in cognitively healthy older adults has been largely negative for memory enhancement; however, observational evidence links higher omega-3 status with better memory performance, especially in populations with low baseline omega-3 levels.

ALA omega-3 from flaxseed is associated with neuroprotection and reduced cognitive decline in observational studies. Animal research with flaxseed oil specifically showed prevention of short-term memory and visuospatial memory impairment in a hyperammonemia model, with preserved prefrontal cortex neuronal morphology.

Folic acid (vitamin B9) participates in one-carbon metabolism, DNA methylation, and homocysteine regulation critical for neuronal function. A large 3-year RCT (n=819, 800 µg/day) found folic acid supplementation significantly improved memory, processing speed, and sensorimotor speed in adults aged 50–70 with elevated homocysteine. Evidence is strongest in populations with elevated homocysteine or borderline deficiency.

Poria cocos polysaccharides (PCP) and essential oils have shown neuroprotective effects in Alzheimer's disease rat models, improving performance in Y-maze, Morris water maze, and novel object recognition tests. Mechanisms include acetylcholinesterase inhibition, reduction of hippocampal neuronal apoptosis, and suppression of MAPK/NF-κB signaling.

In vitro studies published in the Journal of Alzheimer's Disease show fulvic acid inhibits and disassembles tau protein paired helical filaments, a key mechanism in Alzheimer's-related memory loss. A 2025 systematic review concluded fulvic acid shows promise for healthy brain aging and cognitive health.

Preclinical evidence shows Ganoderma lucidum spore extract prevents learning and memory impairment in a rat model of sporadic Alzheimer's disease, acting via inhibition of NF-κB/NLRP3 neuroinflammation. A Cochrane-style systematic review protocol has been registered to evaluate human RCT evidence for cognitive decline.

Gardenia jasminoides extracts rescued memory loss in a Drosophila Alzheimer's disease model overexpressing Aβ protein. Geniposide shows neuroprotective effects in rodent models of Alzheimer's and Parkinson's disease relevant to cognitive decline. Gardeniae Fructus is prescribed in TCM for brain aging and age-related cognitive conditions.

Gardenia jasminoides extracts (particularly crocin-rich fractions) have reversed memory loss in Drosophila and mouse Alzheimer's disease models. Crocin from gardenia protects hippocampal neurons from oxidative damage, modulates MAPK to suppress tau phosphorylation, and reduces neuroinflammation—effects linked to improved spatial cognitive performance in rodents. Evidence is preclinical.

Multiple animal studies and a preclinical review confirm gastrodia and gastrodin improve memory in amnesic, Alzheimer's, and stress models. Mechanisms include hippocampal neuroprotection, reduced amyloid deposition, cholinergic pathway restoration, and BDNF upregulation.

Ginkgo biloba extract (EGb) is one of the most extensively studied botanicals for memory and cognitive function, used traditionally in China and now globally. Evidence from RCTs is mixed: some trials in elderly patients with mild-to-moderate cognitive impairment show improvements in memory and cognitive scales, while the large GEM trial (n=3,069) found no significant effect in healthy older adults. It is best supported in populations with existing cognitive decline.

Ginkgolides are terpene lactone constituents of standardized Ginkgo biloba extract (2.8–3.4% ginkgolides A, B, C) that contribute to its neuroprotective and cognitive effects. Ginkgolide B specifically inhibits platelet-activating factor and β-amyloid neurotoxicity. Their activity is documented within the context of EGb 761 clinical trials showing memory improvements in mild cognitive impairment and Alzheimer's disease.

Ginkgosides are flavonol glycosides comprising approximately 22–27% of standardized Ginkgo biloba extract, contributing to its antioxidant and neuroprotective properties that underlie the cognitive benefits observed in clinical trials. They work alongside ginkgolides and bilobalide (terpene components) in standardized EGb 761 preparations studied in RCTs for memory and cognitive function.

Panax ginseng has been used in traditional Chinese and Korean medicine for millennia for memory, cognitive vitality, and combating mental fatigue. Multiple RCTs demonstrate improvements in working memory, attention, and cognitive performance in healthy adults. Active ginsenosides modulate acetylcholine, dopamine, and BDNF signaling. Typical studied dose is 200–400 mg/day of standardized extract.

Ginsenosides are the principal bioactive triterpenoid saponins of Panax ginseng responsible for its cognitive and memory-enhancing effects. They modulate cholinergic, dopaminergic, and serotonergic neurotransmission and promote BDNF expression. RCTs using ginsenoside-standardized Ginseng extracts document improvements in working memory and processing speed in healthy adults.

Animal studies demonstrate G. littoralis extract reverses scopolamine-induced memory impairment via BDNF/CREB upregulation and NF-κB/MAPK suppression. A separate murine study showed GLE promotes hippocampal neurogenesis by increasing BDNF and TrkB protein levels.

Glutamic acid acting at NMDA receptors is essential for the induction of hippocampal long-term potentiation (LTP), the primary cellular model for memory encoding. Blockade of NMDA receptors with antagonists consistently impairs spatial and declarative memory across species, including humans. L-glutamic acid (but not the D-form) has been shown to enhance memory retention in experimental models via NMDA and non-NMDA receptor activation.

Glycine acts as a co-agonist at NMDA receptors, which are central to synaptic plasticity and memory consolidation. A small RCT (File et al., 1999) found glycine supplementation improved memory and attention in young and middle-aged adults. GlyNAC trials in older adults documented improvements in cognitive function including memory-relevant measures.

LBP has demonstrated significant memory-protective effects in multiple animal models including Alzheimer's disease, sleep apnea, and radiation-induced models. A pilot human study in elderly subjects (n=45, 12 g/day goji powder) reported improved memory retention scores. LBP reduces hippocampal oxidative stress and neuroinflammation—core mechanisms for memory consolidation.

Multiple clinical trials and a meta-analysis support modest improvements in working memory with Gotu Kola supplementation. A 2016 RCT found 750 mg and 1,000 mg daily improved cognitive function in post-stroke patients versus folic acid. A systematic review confirmed working memory benefits but found insufficient evidence for other cognitive domains. Evidence is promising but limited by small sample sizes.

Alpha-GPC (alpha-glycerophosphocholine) is a highly bioavailable choline precursor that readily crosses the blood-brain barrier to support acetylcholine synthesis. Clinical studies show benefits in memory and cognitive function in patients with early Alzheimer's disease and age-related cognitive decline. A comprehensive review confirmed choline compounds including alpha-GPC as effective strategies for boosting memory.

A randomized double-blind placebo-controlled trial in 96 healthy older adults found 250 mg/day standardized grape juice extract significantly improved immediate and delayed memory, visuospatial abilities, language, and attention within 14 days and further at 84 days. Smaller studies suggest resveratrol improves cerebral blood flow and memory in older adults. Evidence is preliminary but human.

A double-blind, placebo-controlled RCT in elderly subjects with mild cognitive impairment showed GSPE (320 mg/day, 6 months) improved MoCA cognitive scores, including memory domains. In vitro, GSEe inhibits acetylcholinesterase (AChE), increasing acetylcholine availability critical for memory formation. Animal models confirm OPCs improve spatial memory in AD mouse models.

Human and preclinical studies collectively support GMT's memory-enhancing properties. The Wightman et al. DBRPCT found that 950 mg GMT attenuated accuracy decline on the picture recognition memory task. MCI patient studies using GMT with Bacopa monnieri showed improved performance on concentration and memory tests, and animal studies confirmed reversal of scopolamine-induced memory impairment.

Human clinical trials and meta-analyses support green tea's benefit for memory and attention. A systematic review (ScienceDirect, 2017) of human studies found evidence that green tea improves cognition including memory and attention. A double-blind RCT in 91 patients with mild cognitive impairment found a combination of green tea extract and L-theanine improved memory and attention scores. A meta-analysis found green tea consumption inversely associated with cognitive impairment (OR 0.63, 95% CI 0.54–0.73).

Human and animal evidence suggests guarana can modulate memory-related processes. In a rat model of hyperlipidemia-induced cognitive impairment, guarana improved memory and reduced acetylcholinesterase activity in brain tissue. In human trials, secondary memory improvements have been observed in placebo-controlled settings. The mechanism involves methylxanthine-mediated adenosine blockade facilitating norepinephrine-dependent memory consolidation.

Human clinical trial data indicate that hesperidin-enriched supplement consumption improves memory performance and cognitive function, particularly in older adults. Animal models confirm memory-enhancing effects via hippocampal neurogenesis, cholinergic function improvement, and BDNF elevation. Hesperidin reduces memory impairment in multiple preclinical paradigms.

Steroidal alkaloids from H. antidysenterica, including conessine, are documented acetylcholinesterase (AChE) inhibitors in peer-reviewed biochemical studies (Life Sciences, 2012). AChE inhibition is a recognized mechanism in cognitive pharmacology. Anti-amnesic properties are listed in pharmacological reviews; no human memory trials exist.

Huperzine A is a natural acetylcholinesterase inhibitor extracted from the Chinese herb Huperzia serrata, traditionally used in Chinese medicine. A meta-analysis of 20 RCTs (n=1,823) found it significantly improved MMSE, Wechsler Memory Scale, and Hasegawa Dementia Scale scores in Alzheimer's disease versus placebo. A US Phase II trial in 210 mild-to-moderate Alzheimer's patients evaluated it at 200–400 µg twice daily.

A double-blind, placebo-controlled RCT (n=100, 120 days) found that a standardised Boswellia serrata and Terminalia chebula combination significantly improved cognitive function, learning, delayed recall, and peripheral BDNF levels in ageing adults with memory complaints (Frontiers in Nutrition, 2025; PMC12719083).

A 21-day randomized, double-blind, placebo-controlled trial (Bairy et al., 2004; n=30 healthy volunteers, 500 mg/day aqueous extract) found significant improvements in verbal learning, immediate logical memory, and short-term logical memory versus placebo. T. cordifolia is classified in Ayurveda as a Medhya Rasayana (intellect-promoting tonic). Animal studies additionally demonstrate protection against cyclosporine-induced hippocampal neurodegeneration.

Iodine deficiency impairs thyroid hormone availability in the brain, disrupting memory consolidation and recall. Population data link low urinary iodine concentration to poorer performance on word learning and recall tests in older adults. Animal models and human studies of hypothyroidism both show memory deficits that are reversible with thyroid hormone repletion. The mechanism operates through thyroid hormones' regulation of hippocampal plasticity.

Gypenosides improved spatial learning and memory in a rat model of chronic cerebral hypoperfusion by suppressing oxidative stress and astrocytic activation in the cortex and hippocampus. Additional rodent studies show protection of hippocampal cells from hypoxia/hypoglycemia injury.

Jujube aqueous extract improved working memory and reversed neurochemical deficits in D-galactose–treated aged rats, outperforming tacrine on cholinesterase inhibition. Seven chemical markers in jujube — including spinosin, quercetin rutinoside, and cAMP — possess documented neuroprotective activity. Jujube also inhibits acetylcholinesterase and enhances choline acetyltransferase activity. Evidence is preclinical.

Kanna's PDE4 inhibition, which elevates cAMP and activates the CREB pathway, provides a mechanistic link to memory consolidation. A 2014 proof-of-concept RCT found Zembrin improved cognitive flexibility and executive function in middle-aged adults. EEG studies show increased activity in frontotemporal regions associated with memory retrieval. Traditional use also includes use for memory improvement.

Resveratrol from knotweed has shown neuroprotective effects in human trials relevant to memory, including improving MMSE scores in mild cognitive impairment and promoting non-amyloidogenic processing of amyloid precursor protein. It increases BDNF, critical for neuroplasticity and memory consolidation. Knotweed constituents cross the blood-brain barrier.

An RCT (Konagai et al., Clinical Interventions in Aging 2013; n=45 healthy elderly) found krill oil supplementation improved working memory performance versus sardine oil and placebo, with significant prefrontal oxyhemoglobin changes detected by fNIRS. Multiple animal models show krill oil attenuates memory impairment in aging and Alzheimer's models.

Puerarin has demonstrated neuroprotective and memory-improving properties in multiple animal models, including diabetic and ischemic rat models. Mechanisms include anti-inflammatory and antioxidant effects in the hippocampus, acetylcholinesterase inhibition, and reduced neuronal apoptosis. Human clinical evidence is currently absent but preclinical evidence is substantial.

ALC (acetyl-L-carnitine) has been studied in multiple RCTs for memory and cognitive function, with a 2003 meta-analysis showing significant advantage on clinical and psychometric scales. A Mendelian randomization study (PMC 2024) found lower genetically predicted ALC levels causally associated with adverse neurocognitive outcomes.

Two RCTs in healthy elderly adults found that carnosine/anserine supplementation preserved verbal episodic memory over 3 months compared with placebo. MRI data in one trial showed suppression of age-related decline in posterior brain blood flow. The evidence is promising but based on small trials using mixed anserine/carnosine formulas.

NAC has been investigated for cognitive function and memory via its role in reducing neuroinflammation, oxidative stress, and modulating glutamate signaling in the CNS. A 2015 systematic review found favorable evidence for NAC in Alzheimer's disease. Clinical trials in bipolar disorder have also shown cognitive improvements with NAC treatment.

Glycine is an obligate co-agonist at NMDA receptors, which are central to synaptic plasticity and memory consolidation. Clinical RCTs with GlyNAC in older adults show measurable improvements in cognitive function including memory. Glycine sleep studies also document improvements in memory recognition tasks the morning after supplementation.

L-serine, as the biosynthetic precursor to D-serine, supports hippocampal NMDA-receptor function critical for long-term potentiation (LTP) and spatial memory. In serine-deficiency disorders, severe memory and cognitive impairments are directly reversed by L-serine supplementation. Experimental epilepsy models show D-serine deficiency impairs hippocampal LTP and spatial learning, both rescued by serine repletion.

Human RCTs provide mixed but partially positive evidence for L-theanine's effects on memory and cognition. A 2021 PubMed-indexed RCT in middle-aged and older adults concluded that L-theanine may improve attention, working memory, and executive function. A 2025 meta-analysis of five RCTs (148 healthy adults) found dose-dependent effects on rapid visual information processing and recognition reaction time, though effects on other cognitive domains were non-significant. Animal studies demonstrate reversal of scopolamine-induced amnesia and increased BDNF expression in the hippocampus.

RCTs show that specific L. plantarum strains improve memory function in older adults with declining cognition and in stressed younger adults. A 12-week RCT of OLL2712 in adults over 65 specifically targeted memory via neuroinflammatory modulation.

A study of 144 healthy volunteers using the Cognitive Drug Research (CDR) computerized battery assessed the olfactory impact of lavender essential oil on cognitive performance and mood. Preclinical data show lavender oil inhalation reverses spatial memory loss in dementia animal models. Evidence in healthy humans is mixed, with some studies showing calming effects that may impair speed of processing.

Lecithin is a precursor of choline and hence acetylcholine, a neurotransmitter critical for memory and learning. Clinical trials in Alzheimer's patients have generally shown no benefit, though one trial in subjective memory impairment showed modest effects. A 2025 multicenter RCT in older adults found lecithin (phosphatidylcholine) alleviated memory deficits. Results are mixed overall.

Lemon balm has traditionally been attributed memory-enhancing properties and shows evidence for cholinergic receptor activity relevant to memory. Clinical trials show improved memory task performance in healthy adults at high single doses, and RCTs in Alzheimer's patients show stabilisation of cognitive function. Evidence in healthy populations is dose-dependent and limited to acute designs.

Lion's Mane (Hericium erinaceus) has been used in traditional Chinese medicine as a tonic for stress and cognitive health. A landmark 2009 double-blind RCT found 3,000 mg/day for 16 weeks significantly improved cognitive function in adults with mild cognitive impairment. Active compounds hericenones and erinacines promote nerve growth factor (NGF) synthesis, supporting neuroplasticity. Evidence is early-stage and requires replication in larger trials.

Low-dose lithium orotate has been shown to reverse memory loss and prevent cognitive decline in aging Alzheimer's mouse models in a 2025 NIH-reported study. Lithium stimulates hippocampal neurogenesis and BDNF upregulation, mechanisms directly relevant to memory. Human clinical evidence for orotate-specific memory improvement remains preclinical or extrapolated.

Lotus seed proanthocyanidins and neferine improve memory and cognitive performance in rodent amnesia models via antioxidant, cholinesterase-inhibitory, and anti-inflammatory mechanisms. No human memory trials exist for lotus seed.

Multiple RCTs and a systematic review show lutein supplementation selectively improves visual episodic memory and learning in both younger and older adults. A 6-month double-blind RCT in 90 adults (aged 40–75) found significant improvements in visual episodic memory and visual learning versus placebo. A 2020 systematic review of five RCTs confirmed consistent benefit for visual episodic memory, with more limited effects on other memory domains.

Luteolin consistently improves memory in animal models of scopolamine-induced amnesia and amyloid-β toxicity. A clinical study of PEA+luteolin in COVID-19 patients showed improvement in memory loss (brain fog). Luteolin induces neurotrophic factor synthesis and protects hippocampal neurons.

Lychee seed extracts and saponins have improved spatial learning and memory in rat models of type 2 diabetes-associated cognitive impairment and Alzheimer's disease, assessed by Morris water maze. Mechanisms include reduction of Aβ, AGEs, and Tau protein in the hippocampus, and improvement of insulin resistance in the brain. TCM also documents lychee seed aqueous extracts improving learning and memory in mice.

Animal studies consistently show maca improves memory impairment induced by scopolamine, ethanol, or ovariectomy, and preserves cognitive function in middle-aged mice via mitochondrial upregulation. Limited human data are positive but insufficient for firm conclusions.

Multiple RCTs demonstrate that magnesium L-threonate supplementation improves episodic and working memory in adults. A 12-week RCT in older adults with mild cognitive impairment found that MgT produced a cognitive score improvement equivalent to approximately 9 years of cognitive rejuvenation. The mechanistic basis involves magnesium's regulation of NMDA receptor plasticity and support for synaptic density, processes central to memory encoding and consolidation.

Honokiol demonstrates neuroprotective effects against beta-amyloid and oxidative damage in neuronal cell models, and reduces cognitive decline in cerebral ischemia animal models. Honokiol activates SIRT3, modulates the amyloidogenic pathway, and crosses the blood-brain barrier readily. No dedicated human memory RCTs exist, but preclinical mechanistic evidence is substantial.

Multiple clinical trials have shown that MCT-induced ketosis can improve memory recall, particularly in individuals with MCI or early Alzheimer's disease where cerebral glucose hypometabolism reduces available neural energy. A key RCT found significant ADAS-cog improvement in 140 Alzheimer's patients supplemented with 20 g/day C8-rich MCT oil over 45 days.

Methylcobalamin is the bioactive, neurologically active form of vitamin B12 used directly for myelin synthesis, neuronal repair, and homocysteine regulation. It is the preferred B12 form for cognitive and neurological applications. Deficiency causes progressive memory impairment and dementia, and clinical studies in deficient and elderly populations show memory improvements with methylcobalamin repletion.

M. officinalis oligosaccharides significantly improved learning and memory in Aβ25-35-induced dementia model rats, and bajijiasu protected against cognitive impairment in APP/PS1 Alzheimer mice. Mechanisms include enhanced monoamine neurotransmitter levels, cholinergic system support, and antioxidant neuroprotection.

Mulberry extract has demonstrated memory-improving effects in animal models of aging and cognitive impairment. Freeze-dried mulberry extract improved learning and memory in D-galactose-induced cognitive impairment models. Preclinical evidence is strong but human clinical RCTs for memory endpoints are lacking.

Multiple preclinical studies in rodents document promnesic (memory-improving) and anti-amnesic effects of POEE, attributable to AChE inhibition in hippocampal memory circuits and serotonin receptor modulation. In an Alzheimer mouse model, the extract attenuated cognitive impairment and neuroglial degeneration. Evidence remains preclinical.

The 2025 RCT (n=100, 120 days) of a TC + Boswellia combination showed significant improvements on the Rey's Auditory Verbal Learning Test in adults with memory complaints. TC extract also prevented scopolamine-induced amnesia in mice via acetylcholinesterase inhibition and antioxidant protection.

NAC has been investigated for memory and cognitive function in clinical trials, particularly in neurodegeneration and schizophrenia. A controlled trial in multiple sclerosis patients found NAC significantly improved cerebral glucose metabolism in brain regions linked to memory and cognition. A meta-analysis found NAC improved working memory as a domain of schizophrenia symptoms after ≥24 weeks of treatment.

Naringin ameliorates memory deficits in multiple experimental paradigms including Alzheimer's disease and mitochondrial dysfunction models. It inhibits acetylcholinesterase, upregulates AMPK-mediated autophagy for Aβ clearance, and reduces neuroinflammation. Evidence is entirely preclinical; no human memory trials have been published.

NR was tested in a 24-week RCT for cognitive outcomes in long-COVID patients; it raised NAD+ but did not significantly improve memory or cognition versus placebo at primary endpoints, though exploratory analyses suggested within-group benefits at 10 weeks. In the Parkinson's disease NADPARK trial, NR was associated with altered cerebral metabolism and mild clinical (including cognitive) improvement. Preclinical evidence shows NR enhances cognition via neuroinflammation reduction and synaptic plasticity.

Preclinical studies show NMN prevents diabetes-induced hippocampal neuronal loss and memory deficits, and rescues neurovascular coupling and cerebromicrovascular endothelial function in aged mice. A small human RCT (n=20 older men, 250 mg/day, 12 weeks) increased blood NAD+ but did not show significant improvement on cognitive assessments, likely due to insufficient power.

EVOO consumption has been associated with preserved memory function in aging adults in both RCTs and epidemiological studies. A 2022 RCT in mild cognitive impairment showed EVOO improved behavioral scores and enhanced brain activation in cortical regions involved in memory. PREDIMED data link olive oil supplementation to improved memory and frontal cognition.

Omega-3 fatty acids, particularly DHA and EPA, are structural components of neuronal membranes critical for memory, synaptic plasticity, and neuroprotection. Expert reviews identify omega-3 DHA as among the five most evidence-supported supplements for memory. Multiple RCTs show improvements in attention, memory, and processing speed with omega-3 supplementation, especially in older adults.

A limited number of clinical trials have shown that hesperidin-enriched dietary supplements improve cerebral blood flow and memory performance. A 2025 Frontiers in Nutrition review described hesperidin as neuroprotective with emerging clinical evidence for cognition and memory in age-related decline.

A 16-week RCT found daily unsalted skin-roasted peanut consumption improved verbal memory and brain vascular function in older adults. Peanuts are rich in niacin, vitamin E, and resveratrol, all linked to cognitive protection. Niacin from food intake has been prospectively associated with slower cognitive decline in large observational studies.

Prolyl endopeptidase (PREP) is expressed in hippocampal regions of the human brain and degrades neuropeptides associated with learning and memory. Genetic knockout mouse models deficient in PREP show reduced hippocampal synaptic spine density, impaired long-term potentiation, and spatial memory deficits. PREP inhibitors improved memory and cognitive function in rodents, monkeys, and early human trials, though clinical translation has been limited.

Perilla frutescens extract and rosmarinic acid improved cognition and memory in amyloid-beta-injected mouse models. A 12-month human RCT with perilla seed oil showed improved cognitive index scores in Japanese seniors. Fermented perilla has been shown to increase BDNF expression and improve hippocampal plasticity in preclinical models.

Berberine from P. amurense is described as 'neuroprotective and neurotrophic,' and enhanced neurite formation in rat PC12 cells by 30% in vitro at 5 µg/mL. Phellodendri Cortex has documented neuroprotective activities in preclinical research. A TCM formula (Chunghyuldan) containing P. amurense has been studied for neuroprotective properties. Evidence is preclinical; dedicated human memory RCTs are lacking.

Phosphatidylcholine (PC) is a direct precursor of acetylcholine, the neurotransmitter central to memory formation. Higher dietary PC intake is associated with lower dementia risk in large observational cohorts. A placebo-controlled clinical trial demonstrated significant improvement in explicit memory with acute PC supplementation. Clinical evidence is present but effect sizes in healthy adults are modest.

Phosphatidylserine (PS) is a phospholipid concentrated in neuronal membranes that supports cell membrane fluidity and neurotransmitter release. Multiple RCTs demonstrate PS supplementation improves memory recall and learning in older adults with age-related cognitive decline. The FDA has granted a qualified health claim for PS and reduced risk of cognitive dysfunction in the elderly. Typical studied dose is 300 mg/day.

Multiple clinical trials show Pycnogenol (pine bark extract) significantly improves memory, especially spatial working memory, in older adults. Spatial working memory improved by 10.9% versus placebo in a double-blind trial. Studies support both short-term memory enhancement and protection against age-related memory decline.

Multiple RCTs and a 2019 PMC review confirm Pycnogenol improves memory, particularly spatial memory, in elderly individuals and those with mild cognitive impairment. Human clinical trials show improvements in memory, learning, and daily cognitive capabilities. Antioxidant neuroprotection and vascular mechanisms are implicated.

P. tenuifolia is one of the best-studied TCM herbs for memory, with preclinical evidence spanning scopolamine-induced amnesia models, aged animal models, and Alzheimer's disease mouse models. One small human trial reported improvement in spatial and verbal memory. Mechanisms include AChE inhibition, BDNF upregulation, anti-amyloid effects, and synaptic plasticity enhancement.

Memory enhancement is the best-evidenced application of Polygala root, with human clinical trials in elderly subjects demonstrating significant improvement using the BT-11 extract. The root is officially listed in the Chinese Pharmacopoeia for improving memory and cognitive function. A 2025 meta-analysis ranked it highest among natural extracts for overall cognitive function.

A human RCT (n=28 middle-aged adults with memory complaints) found pomegranate juice daily for 4 weeks improved verbal and visual memory scores. Preclinical studies support neuroprotective effects. Evidence in humans is limited to small trials but the biological rationale is supported by pomegranate's antioxidant and anti-neuroinflammatory properties.

Pregnenolone sulfate enhances acetylcholine release in hippocampus and cortex, circuits central to memory encoding. Animal studies robustly show pregnenolone and its sulfate reverse age-related memory deficits. Human clinical trials in schizophrenia populations show improvements in verbal and working memory with pregnenolone supplementation.

Multiple double-blind, placebo-controlled RCTs have documented PQQ disodium salt improving composite memory and verbal memory in both younger and older adults at 20 mg/day over 8–12 weeks. Co-administration with CoQ10 further enhanced word recall. Working memory improvements have also been reported across trials.

Human clinical trial evidence for quercetin's direct effect on memory is mixed and largely negative. A large RCT (n=941, 500 or 1000 mg/day for 12 weeks) found no significant effects on memory, psychomotor speed, reaction time, attention, or cognitive flexibility despite large increases in plasma quercetin. A small RCT using a quercetin-enriched herbal combination (1500 mg/day for 8 weeks) showed improved working memory in menopausal women, but the multi-herb formula prevents attribution to quercetin alone.

Catalpol and Rehmannia oligosaccharides improve learning and memory in multiple animal models. Catalpol ameliorated cognition deficits and oxidative brain damage in D-galactose-induced senescent mice. Rehmannia oligosaccharides improved learning ability and reduced amyloid-beta deposition in C. elegans AD models. The Herbal Reality monograph cites neuroprotective effects against Alzheimer's disease from a systematic catalpol review.

Catalpol, the primary iridoid glycoside in rehmannia, exerts neuroprotective effects relevant to memory, improving cognitive function in aged and Alzheimer's model animals. It upregulates hippocampal GAP-43, protects synaptic proteins from amyloid-beta damage, and enhances BDNF and PKC in hippocampal neurons. TCM considers rehmannia a primary herb for age-related memory loss.

A small human RCT in breast cancer patients found reishi spore powder improved cognitive function during endocrine therapy compared to controls. MSKCC notes a pilot study in Alzheimer's disease did not find benefit. Preclinical data show neuroprotective mechanisms including antioxidant and anti-neuroinflammatory activity. Human evidence for memory/cognition in healthy adults is limited.

Resveratrol is a polyphenolic stilbene found in grapes and berries studied for neuroprotection and memory support. A 2017 double-blind RCT (n=60, age 50–75, 200 mg/day, 26 weeks) found resveratrol significantly improved word retention and verbal memory versus placebo. Mechanisms include SIRT1 activation, amyloid-β clearance, cerebrovascular protection, and BDNF upregulation.

Rhodiola rosea (golden root) has been used in traditional medicine across Russia, Scandinavia, and China to combat fatigue and enhance mental performance. A 2018 systematic review and meta-analysis of 36 preclinical studies found significant improvements in learning and memory function in animal models. Human evidence is primarily for reduction of mental fatigue and stress-induced cognitive impairment, with adaptogenic mechanisms supporting memory.

Both oral supplementation and aromatherapy with rosemary have shown memory benefits in human clinical trials. A crossover RCT in elderly adults found 750 mg of dried rosemary leaf improved speed of memory versus placebo. Inhaled rosemary essential oil enhanced overall memory quality and alertness in healthy adults. Oral rosemary also improved prospective and retrospective memory in a university student RCT.

RA-standardized Melissa officinalis extracts have improved memory measures in human clinical trials, including word recognition in healthy adults and cognitive stabilization in mild-to-moderate Alzheimer's disease. Preclinical models show RA reduces amyloid-beta aggregation and prevents Aβ-induced memory impairment. Evidence is based primarily on RA-containing plant preparations rather than isolated RA.

Preclinical studies robustly show RJ improves spatial memory and reduces neurodegeneration in rodent Alzheimer's and vascular dementia models. One human trial using a combination product (RJ + ginkgo + ginseng) improved cognitive scores in mild cognitive impairment (MCI), but RJ's isolated contribution is unconfirmed.

Rutin improved cognitive deficits and brain damage in rat models of chronic cerebral hypoperfusion, reversing cholinergic dysfunction, oxidative damage, and neuroinflammation in the hippocampus. It also attenuated scopolamine-induced learning and memory impairment in rats by activating BDNF/TrkB/ERK/CREB/Bcl2 neuroprotective pathways.

Saffron (Crocus sativus) has traditional use in Persian and Ayurvedic medicine for memory and mood. A meta-analysis of 4 RCTs found saffron at 30 mg/day significantly improved ADAS-cog cognitive scores in Alzheimer's patients. Multiple RCTs show saffron is non-inferior to donepezil and memantine in mild-to-moderate Alzheimer's disease, with active compounds crocin and safranal providing neuroprotective effects.

Multiple human clinical trials demonstrate that S. officinalis acutely improves memory and cognitive performance in healthy adults through cholinesterase inhibition. A systematic review confirmed benefits in both healthy subjects and Alzheimer's patients. European folk medicine use for memory enhancement predates and motivated this clinical research.

SAMe is a pivotal methylation metabolite in neuronal homeostasis, and SAMe deficiency has been documented in Alzheimer's disease (AD) brain tissue. An open clinical trial in elderly patients with cognitive impairment showed statistically significant improvements in Mini-Mental State Examination scores after two months of SAMe treatment. A Phase II RCT is underway targeting p-tau181 reduction and cognitive outcomes in mild cognitive impairment and AD. Evidence is preliminary and largely mechanistic; no large-scale completed RCTs have established efficacy.

The PDE4-cAMP-CREB pathway targeted by sceletium's alkaloids is directly implicated in memory consolidation and recall. A proof-of-concept RCT in healthy older adults reported positive cognitive outcomes including memory-related parameters. Sceletium has a documented traditional reputation for enhancing mental performance, including memory.

Schisandrin reversed amyloid-β and scopolamine-induced memory impairment in animal models by increasing antioxidant enzymes and reducing oxidative damage in brain tissue. Small human studies report improved memory and reduced mental fatigue with schisandra extract. A 2017 human study found reduced amyloid plaque accumulation in Alzheimer's patients taking schisandra.

Schisandrin and schisandrin A improve spatial learning and memory in multiple Alzheimer's disease rodent models via SIRT1 upregulation, NF-κB inhibition, reduction of amyloid-β accumulation, and modulation of microglial polarization. Small human studies associate Schisandra extract with improved memory and reduced mental fatigue.

A. julibrissin has been shown to protect learning and memory against scopolamine-induced amnesia in mice, and to ameliorate memory loss caused by sleep deprivation in Drosophila. TCM also historically lists poor memory among its indications.

Animal and in vitro studies show silymarin improves spatial working memory and reduces anxiety-related behaviors. Preclinical evidence suggests neuroprotective effects relevant to memory via anti-inflammatory and antioxidant CNS mechanisms. Human evidence for memory-specific outcomes is very limited and largely confined to co-administration studies and surrogate biomarker data.

Epidemiological evidence from East Asian populations links dietary soy isoflavone intake with better memory and lower dementia risk. S-equol, the active gut-derived metabolite, is associated with reduced vascular brain pathology relevant to memory. RCT evidence in Western populations is mixed due to low equol-producer rates.

Multiple RCTs and a meta-analysis of 16 trials support a modest beneficial effect of soy isoflavones on memory and overall cognitive function in older adults. Results are mixed across individual studies, with equol-producer status appearing to modulate response.

Soy isoflavones have been studied for effects on memory and cognitive function via interaction with estrogen receptors in the brain and antioxidant mechanisms. Observational studies and randomized controlled trials in humans have yielded inconclusive results, with approximately 50% of studies showing positive effects and the other half showing null or negative findings. Neuroprotective effects of isoflavones have been demonstrated in animal studies.

A randomized, double-blind, placebo-controlled trial (90 subjects; 90 days; 900 mg/day) found spearmint extract improved working memory and spatial working memory by 15% and 9%, respectively, in adults with age-associated memory impairment. Rosmarinic acid is the proposed active constituent, acting via antiacetylcholinesterase and neuroprotective mechanisms.

Higher green leafy vegetable consumption — including spinach (specifically assessed on food frequency questionnaires) — was associated with significantly slower cognitive decline in a large prospective cohort study. Participants eating ~1.3 servings/day showed cognitive function equivalent to being 11 years younger.

Stigmasterol improved spatial learning and memory in animal models of neurotoxin-induced memory loss and Alzheimer's disease, reducing escape latency in Morris water maze tests and decreasing Aβ42 levels in brain tissue. Evidence is entirely preclinical.

Sulforaphane improves memory in multiple preclinical models by reducing hippocampal neuroinflammation, increasing BDNF, and restoring synaptic plasticity. A 2025 systematic review and meta-analysis confirmed consistent cognitive-protective effects in rodent models. Human RCTs show processing speed and some memory domain improvements.

P. glomerata extract supplementation improved learning and memory in aged mice over 150 days in a published pharmacological study. Anticholinesterase and antiglycation activity of P. glomerata fractions have also been reported in vitro, providing mechanistic support for cognitive effects.

A. calamus has documented acetylcholinesterase inhibitory activity and memory-enhancing effects in animals. A small clinical study in children (Ayushdhara journal) found significant memory improvement with 250 mg Vacha rhizome twice daily over 48–96 days. Traditional Ayurvedic use for memory loss is among its oldest documented applications.

Preclinical studies have demonstrated that Aster tataricus extract (ATE) ameliorates memory dysfunction in rodent models. A Korean aster species study showed ATE modulates hippocampal cholinergic activity and anti-apoptotic pathways in scopolamine-induced cognitive deficit models. ATE also mitigated amyloid-β aggregation and neuronal apoptosis in transgenic mouse models, improving memory-related functions.

Taurine enhances hippocampal neurogenesis and synaptogenesis, and animal studies consistently demonstrate improvements in learning and memory. Clinical associations between lower taurine levels and cognitive decline exist, though dedicated human memory RCTs are lacking.

A randomized, double-blind, placebo-controlled clinical trial found that a standardized combination of T. chebula and Boswellia serrata (300 mg/day, 120 days) significantly improved memory outcomes — including total learning, delayed recall, and immediate recall — in adults aged 40–65 with subjective memory complaints, alongside improved serum BDNF levels.

As the carrier ligand in magnesium L-threonate (MgT), threonic acid facilitates brain magnesium delivery, upregulating NR2B-containing NMDA receptors and increasing synaptic density. Multiple RCTs in humans have shown significant improvements in working and episodic memory. The threonate ligand itself has been shown in cell studies to directly elevate intraneuronal magnesium and drive the synaptic density effect.

T. cordifolia enhanced memory and cognition in normal rats and reversed cyclosporine-induced memory deficits in animal models. Network pharmacology and metabolomics analyses identify BACE1 and MAOB as potential Alzheimer's disease therapeutic targets. It is classified in Ayurveda as a Medhya Rasayana—a memory-enhancing category.

Epidemiological and case-control studies associate higher circulating tocotrienol levels with better memory and cognitive function outcomes in middle-aged and elderly subjects. The AdNeuroMed study linked low plasma tocotrienols with mild cognitive impairment and Alzheimer's disease. Mechanistic data shows alpha-tocotrienol protects neurons involved in memory processing.

Multiple rodent studies demonstrate pterostilbene improves spatial and recognition memory in models of age-related and chemically-induced cognitive decline. Mechanisms include enhanced cholinergic transmission, hippocampal antioxidant activity, BDNF elevation, and improved synaptic plasticity. No human memory trials have been completed.

Oral tributyrin has been shown in multiple animal models to prevent memory decline, including in Alzheimer's disease mouse models where it attenuated cognitive and behavioral deficits over 18 months. Tributyrin modulates hippocampal synaptic plasticity and preserves epigenetic marks (histone acetylation) in hippocampal neurons. Evidence is currently limited to preclinical studies.

Turmeric (Curcuma longa) contains curcuminoids, with curcumin being the primary active constituent studied for memory and neuroprotection. A 2018 UCLA RCT found bioavailable curcumin improved memory by 28% and reduced brain amyloid/tau accumulation over 18 months. Traditional Ayurvedic medicine has used turmeric for cognitive health for centuries, and epidemiological evidence links Indian dietary turmeric consumption with lower Alzheimer's rates.

Preclinical studies show UA crosses the blood-brain barrier and exerts neuroprotective effects relevant to memory, reducing amyloid pathology and neuroinflammation in animal models. Clinical evidence directly linking UA to memory improvement in humans is still lacking, but emerging data on its effects in the CNS warrant inclusion as scientific based on mechanistic human data.

Vinpocetine, a synthetic derivative of vincamine from the periwinkle plant, increases cerebral blood flow and metabolism. Three RCTs in older adults with memory problems associated with poor brain circulation found significantly greater improvement on global cognitive tests including memory versus placebo. It has been used clinically in Europe for vascular cognitive impairment for decades.

Thiamine deficiency is the established cause of Wernicke-Korsakoff syndrome, a severe amnesia disorder, making B1 one of the best-documented nutrients for memory function. Preclinical models show thiamine deficiency drives AD-like memory deficits, and a pilot RCT with benfotiamine in early Alzheimer's disease demonstrated slowing of cognitive decline.

Vitamin B12 (cobalamin) is essential for myelin synthesis and homocysteine metabolism. Deficiency causes progressive cognitive decline and memory impairment, which is reversible with B12 repletion. Clinical trials show memory improvement following B12 correction in deficient individuals, particularly the elderly. B12 combined with folate reduces elevated homocysteine, a risk factor for cognitive decline.

Vitamin B6 is required for synthesis of neurotransmitters critical to learning and memory, and adequate B6 status is associated with better cognitive indices, particularly in older adults or those with hyperhomocysteinaemia. Evidence from RCTs is mixed and primarily exists for B6 used in combination with other B vitamins.

Folate (vitamin B9) is essential for one-carbon metabolism, DNA methylation, and homocysteine regulation relevant to neuronal function and memory. A large 3-year RCT found folate supplementation significantly improved memory in adults aged 50–70 with elevated homocysteine. Evidence is strongest in populations with elevated homocysteine or deficiency, where memory improvements are clinically meaningful.

5-Methyltetrahydrofolate (5-MTHF) is the bioactive form of folate that crosses the blood-brain barrier to support one-carbon metabolism, neurotransmitter synthesis, and homocysteine regulation critical for memory. It is particularly relevant for individuals with MTHFR gene polymorphisms who cannot efficiently convert folic acid. Evidence for memory improvement parallels that of folate supplementation in older adults with elevated homocysteine.

Clinical and epidemiological evidence links vitamin E status to cognitive function and Alzheimer's disease risk. High plasma vitamin E levels are associated with better cognitive performance, and a reduced risk of developing Alzheimer's disease has been observed in subjects with high vitamin E intake. RCT results are mixed, with one landmark trial showing delayed functional decline in moderate Alzheimer's patients.

A 2023 double-blind RCT found that 12 weeks of 6-MSITC supplementation (the key wasabi isothiocyanate) significantly improved episodic memory—including verbal memory and face-name association—in healthy adults aged 60+. This builds on earlier evidence from ME/CFS patient studies showing reduced brain fog and improved cognitive processing speed. The proposed mechanism involves Nrf2-mediated antioxidant protection and reduction of neuroinflammation.

Memory enhancement is the most extensively clinically studied effect of Waterhyssop. Multiple RCTs and systematic reviews confirm improvements in delayed word recall, memory consolidation, and memory span in both healthy adults and elderly populations.

TCM texts list forgetfulness and poor memory among the classical indications for amber (Hu Po), attributed to its spirit-calming and heart-nourishing actions. No clinical studies have evaluated amber for memory or cognitive outcomes in humans.

Traditional Ayurvedic medicine classifies amla as a 'medhya rasayana'—a brain and memory tonic. Preclinical research shows amla antioxidants protect brain cells from oxidative damage relevant to memory. Human clinical evidence for memory outcomes is lacking.

TCM attributes Poria cocos sclerotium with the ability to sharpen mental clarity and support memory, traditionally linked to its qi-tonifying and mind-calming properties. There is limited preclinical mechanistic data supporting cognitive effects but no clinical evidence.

Preclinical evidence demonstrates that baicalin (S. baicalensis) protects against cognitive impairment and improves performance in learning/memory tasks in animal models of Alzheimer's disease and neuroinflammation via SIRT1/HMGB1 and NLRP3 pathways. Human clinical evidence is not yet established.

Wood betony is documented in European herbalism as a cephalic herb traditionally used to improve memory, concentration, and cognitive clarity. It is described by some herbalists as having nootropic-like qualities. No clinical human evidence exists.